Low serum testosterone levels may be a modifiable risk factor for adverse outcomes and poor quality of life in male patients on haemodialysis, say researchers. In their unadjusted analysis of data from a cohort of male incident patients on haemodialysis (n = 623), higher serum testosterone levels were associated with a significantly decreased risk of death during a median follow-up of 20 months. In their adjusted analyses, low serum testosterone levels were associated with a significant trend towards increased all-cause mortality and with significantly lower Health Utility Index scores.
ORIGINAL RESEARCH PAPER
Bello, A. K. et al. Serum testosterone levels and clinical outcomes in male hemodialysis patients. Am. J. Kidney Dis. doi:10.1053/j.ajkd.2013.06.010
Rights and permissions
About this article
Cite this article
Testosterone levels and adverse outcomes in male patients on haemodialysis. Nat Rev Nephrol 9, 554 (2013). https://doi.org/10.1038/nrneph.2013.158
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2013.158